ICBiotec

Mount Horeb, United States Founded: 1998 • Age: 28 yrs Acquired By eGenesis
Provider of gene editing platform for the development of human-compatible organs, tissues and cells
Request Access

About ICBiotec

ICBiotec is a company based in Mount Horeb (United States) founded in 1998 was acquired by eGenesis in May 2020.. ICBiotec operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.

  • Headquarter Mount Horeb, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    eGenesis

    (May 26, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of ICBiotec

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ICBiotec

ICBiotec has secured backing from 1 investor. Prominent investors backing the company include eGenesis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Gene transplantation platform for humanizing pig cells is developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ICBiotec

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - ICBiotec

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Icbiotec Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ICBiotec

ICBiotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of gene therapy using CRISPR base editing to treat diseases
domain founded_year HQ Location
Gene transplantation platform for humanizing pig cells is developed.
domain founded_year HQ Location
RNA-editing technologies are provided for precision medicine applications.
domain founded_year HQ Location
Next-generation gene editing tools are developed for drug enhancement.
domain founded_year HQ Location
Genetic therapies for diseases are developed using prime editing technology.
domain founded_year HQ Location
A CRISPR-based gene-editing platform is developed for therapeutic applications.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Icbiotec

eGenesis Acquires ICBiotec
Pharmoutsourcing5 years ago

Frequently Asked Questions about ICBiotec

When was ICBiotec founded?

ICBiotec was founded in 1998.

Where is ICBiotec located?

ICBiotec is headquartered in Mount Horeb, United States. It is registered at Mount Horeb, Wisconsin, United States.

What does ICBiotec do?

ICBiotec was established in 1998 in Mount Horeb, United States. A gene editing platform is offered by the company within the biotechnology sector for advancing human-compatible organs, tissues, and cells. Operations are centered on genetic engineering tools and services that support regenerative medicine applications. Focus is placed on research and development activities conducted from the U.S. base, with relevance to therapeutic advancements in organ transplantation and tissue engineering.

Who are the top competitors of ICBiotec?

ICBiotec's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.

Who are ICBiotec's investors?

ICBiotec has 1 investor. Key investors include eGenesis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available